Latest AI and machine learning research in oncology/hematology for healthcare professionals.
This issue of the Biomedical Journal highlights regulatory mechanisms that shape aging, disease progression, and biological complexity across molecular, cellular, and systems levels. A central theme is plasminogen activator inhibitor-1 (PAI-1) as a multifunctional regulator linking fibrinolysis, cellular senescence, stem cell dynamics, fibrosis, and tumor biology. Contributions examine structure-g...
BACKGROUND: N-(1,3-dimethylbutyl)-N'-phenyl-p-phenylenediamine-quinone (6PPD-Q), a transformation product of tire rubber antioxidants, has been increasingly recognized as an emerging environmental contaminant with potential reproductive toxicity. Although growing evidence implicates 6PPD-Q exposure in male infertility, its role in specific pathological conditions such as sertoli cell-only syndrome...
Breast cancer (BC) is a highly heterogeneous malignancy and remains a major cause of cancer-related mortality among women worldwide. Advances in multi...
BACKGROUND & AIMS: Clinical outcomes and histological characteristics of biopsy-proven steatotic liver disease (SLD) subtypes remain understudied. We ...
OBJECTIVE: To evaluate whether a deep learning-based AI system with suspected nodule indexing and malignancy risk stratification improves radiologist ...
Overexpression of MERTK and FLT3 plays a crucial role in activating signal transduction pathways in various human hematological malignancies. These si...
Rectal cancer management has increasingly shifted toward organ-preserving strategies that aim to maintain oncologic control while preserving bowel, ur...
BACKGROUND: Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are heterogeneous tumors with rising incidence, necessitating precise preoperat...
OBJECTIVES: Adrenal tumors can be functional or malignant, yet they are often overlooked in abdominal CT. This study aimed to develop and validate a f...
Lung adenocarcinoma (LUAD) displays significant morphological and molecular heterogeneity both within and between tumors. This heterogeneity, coupled ...
PURPOSE: Sonazoid contrast-enhanced ultrasound (CEUS) offers valuable diagnostic information on hepatic lesions, but it is time-consuming. In this stu...
BACKGROUND: Nearly 250,000 cancer cases are diagnosed annually in Canada, with breast and prostate cancer representing 25% and 22% of new cases, respe...
OBJECTIVES: To train and validate a machine learning model to distinguish paper mill publications from genuine cancer research articles, and to screen...
Identifying predictive and resistance biomarkers remains one of the most relevant unmet needs in clinical cancer research. Artificial Intelligence (AI...
[18F] fluorodeoxyglucose positron emission tomography - computed tomography (FDG PET-CT) is increasingly used for staging of breast cancer in the prim...
Potency (IC50) prediction of small molecules is pivotal for anticancer drug development. This study benchmarked five deep learning (DL) models for IC5...
Various exosome-derived proteins have been reported to play essential roles in regulating colorectal cancer progression and affecting the prognosis of...
Homologous recombination deficiency (HRD) is a critical biomarker in high-grade serous ovarian cancer for the clinical benefit from platinum-based che...
Machine learning (ML), particularly deep learning (DL) and radiomics-based approaches, has emerged as a powerful tool for cancer outcome prediction us...
BACKGROUND: Colorectal cancer (CRC) is one of the most prevalent malignant diseases worldwide and displays significant heterogeneity. The aim of this ...